Lee, B., Kang, K., Jeon, M. J., Yu, E. S., Kim, D. S., Choi, H., . . . Park, Y. (2020). Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: A retrospective multicentre cohort study. Sci Rep.
Chicago ZitierstilLee, Byung-Hyun, et al. "Comparison between 5-day Decitabine and 7-day Azacitidine for Lower-risk Myelodysplastic Syndromes With Poor Prognostic Features: A Retrospective Multicentre Cohort Study." Sci Rep 2020.
MLA ZitierstilLee, Byung-Hyun, et al. "Comparison between 5-day Decitabine and 7-day Azacitidine for Lower-risk Myelodysplastic Syndromes With Poor Prognostic Features: A Retrospective Multicentre Cohort Study." Sci Rep 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.